Modulus Therapeutics Company
Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company that aims to bring cell therapies for autoimmunity into the mainstream. They are focused on accelerating cell therapy discovery through rapid prototyping and generative design. The organization recognizes the limitations of current treatments for autoimmune diseases and is dedicated to developing therapeutics that are optimized for safety and patient access. By leveraging the power of AI, Modulus Therapeutics is revolutionizing the field of cell therapy and working towards providing more effective and personalized treatments for autoimmune patients.
Investors
Headquarters:
Seattle, King County, Washington, United States
Industry:
Early Drug Development
Employee Number:
1-10
Founded Date:
2020






